Human translational studies investigating the neurocognitive effects of 5-HT4 receptor agonism
<p>Major depression is common, costly, and a global cause of significant morbidity. First-line antidepressant medication has a clinically problematic delay before therapeutic efficacy and is ineffective for a subset of those affected. In addition, many patients with depression, as well as othe...
প্রধান লেখক: | De Cates, AN |
---|---|
অন্যান্য লেখক: | Harmer, C |
বিন্যাস: | গবেষণাপত্র |
ভাষা: | English |
প্রকাশিত: |
2022
|
বিষয়গুলি: |
অনুরূপ উপাদানগুলি
-
The role of the 5-HT2C receptor in emotional processing in healthy adults
অনুযায়ী: Rawlings, N
প্রকাশিত: (2010) -
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review
অনুযায়ী: Kyle Arsenault‐Mehta, অন্যান্য
প্রকাশিত: (2024-03-01) -
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression
অনুযায়ী: Severus Emanuel, অন্যান্য
প্রকাশিত: (2012-07-01) -
Towards a neurocognitive understanding of angiotensin-II receptor blockade: insights into memory, stress, and their implications for PTSD
অনুযায়ী: Shkreli, L
প্রকাশিত: (2024) -
Role of oxytocin in modulating addictive behaviour
অনুযায়ী: P. Bach, অন্যান্য
প্রকাশিত: (2021-04-01)